Treating tobacco dependence as a chronic illness and a key modifiable predictor of disease

International Journal of Clinical Practice

Volumn 64, Issue 2, 2010, Pages 142-146

  Foulds, J ^a,b   Schmelzer, A C ^a   Steinberg, M B ^a,b  

^a Department of Emergency Medicine   (United States)

^b ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; C REACTIVE PROTEIN; CLONIDINE; DRUGS USED IN THE TREATMENT OF ADDICTION; NALTREXONE; NICOTINE GUM; NICOTINE INHALER; NICOTINE PATCH; NICOTINE SPRAY; NORTRIPTYLINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; TOBACCO SMOKE; UNCLASSIFIED DRUG; VARENICLINE; VENLAFAXINE;

AORTA ANEURYSM; CANCER RISK; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CHRONIC DISEASE; CLINICAL TRIAL; DRUG EFFECT; DRUG MEGADOSE; DRUG TREATMENT FAILURE; EMPHYSEMA; FOLLOW UP; HEART INFARCTION; HIGH RISK PATIENT; HUMAN; HYPERTENSION; LARYNX CANCER; LUNG CANCER; MOTIVATION; NICOTINE REPLACEMENT THERAPY; PATIENT ATTITUDE; PATIENT COUNSELING; PATIENT MONITORING; PRACTICE GUIDELINE; PREDICTOR VARIABLE; PRIORITY JOURNAL; REVIEW; RISK MANAGEMENT; SMOKING; SMOKING CESSATION; THERAPY EFFECT; THORAX PAIN; TOBACCO DEPENDENCE;

CHRONIC DISEASE; COUNSELING; DRUG THERAPY, COMBINATION; HOTLINES; HUMANS; MOTIVATION; NICOTINIC AGONISTS; PATIENT EDUCATION AS TOPIC; REFERRAL AND CONSULTATION; RETREATMENT; RISK FACTORS; RISK REDUCTION BEHAVIOR; SMOKING CESSATION; TOBACCO USE DISORDER;

EID: 72449189679     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2009.02243.x     Document Type: Review

References (20)

1. U.S. Department of Health and Human Services. The Consequences of Smoking: A Report of the Surgeon General. Washington, DC : U.S. Government Printing Office, 2004.
2. Steinberg MB, Schmelzer AC, Richardson DL, Foulds J. The case for treating tobacco dependence as a chronic disease. Ann Intern Med 2008 148 : 554 556.
3. Tonstad S, Cowan JL. C-reactive protein as a predictor of disease in smokers and former smokers: a review. Int J Clin Pract 2009 63 : 1634 1641.
4. Yusuf S, Hawken S, Ounpuu S et al. INTERHEART Study Investigators. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004 364 : 937 952. (Pubitemid 39208455)
5. Fiore MC, Bailey WC, Cohen SJ et al. Treating Tobacco Use and Dependence: Clinical Practice Guideline. Rockville, MD : US Department of Health and Human Services. Public Health Service, 2000.
6. Fiore MC, Jaén CR, Baker TB et al. Treating Tobacco Use and Dependence: 2008 Update. Clinical Practice Guideline. Rockville, MD : U.S. Department of Health and Human Services. Public Health Service, 2008.
7. Steinberg MB, Akinciquil A, Delnevo C et al. Gender and age disparities for smoking cessation treatment. Am J Prev Med 2006 30 : 405 412.
8. Thorndike AN, Regan S, Rigotti NA. The treatment of smoking by US physicians during ambulatory visits: 1994-2003. Am J Public Health 2007 97 : 1878 1883.
9. Vogt F, Hall S, Marteau TM. General practitioners' and family physicians' negative beliefs and attitudes towards discussing smoking cessation with patients: a systematic review. Addiction 2005 100 : 1423 1431.
10. Doll R, Peto R, Boreham J, Sutherland I. Mortality in relation to smoking: 50 years' observations on male British doctors. BMJ 2004 328 1519.
11. Nusselder WJ, Looman CW, Marang-van de Mheen PJ, Van e Mheen H, Mackenbach JP. Smoking and the compression of morbidity. J Epidemiol Community Health 2000 54 : 566 574.
12. Aveyard P, West R. Managing smoking cessation. BMJ 2007 335 : 37 41.
13. Lundbäck B, Lindberg A, Lindström M et al. Obstructive lung disease in Northern Sweden studies. Not 15 but 50% of smokers develop COPD? - report from the obstructive lung disease in Northern Sweden studies. Respir Med 2003 97 : 115 122.
14. Peto R, Darby S, Dep H, Silcocks P, Whiteley E, Doll R. Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case-control studies. BMJ 2000 321 : 323 329.
15. Scanlon PD, Connett JE, Waller LA, Altose MD, Bailey AS. Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000 161 (2 Pt 1 381 390.
16. Stanbrook MB, Flegel K. A pause for thought on lung cancer screening. CMAJ 2009 180 : 793.
17. Patz EF Jr., Goodman PC. Low-dose spiral computed tomography screening for lung cancer: not ready for prime time. Am J Respir Crit Care Med 2001 163 : 813 814.
18. Bover MT, Foulds J, Steinberg MB, Richardson D, Marcella SW. Waking at night to smoke as a marker for tobacco dependence: patient characteristics and relationship to treatment outcome. Int J Clin Pract 2008 62 : 182 190.
19. Steinberg MB, Greenhaus S, Schmelzer AC et al. Triple-combination pharmacotherapy for medically ill smokers: a randomized trial. Ann Intern Med 2009 150 : 447 454.
20. Han ES, Foulds J, Steinberg MB et al. Characteristics and smoking cessation outcomes of patients returning for repeat tobacco dependence treatment. Int J Clin Pract 2006 60 : 1068 1074.